LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW) by Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson

1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) by Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson

Relevância e representação fidedigna da informação de ativos financeiros mensurados a valor justo by Vinícius Gomes Maertins, Marcio André Veras Machado, Aldo Leonardo Cunha Callado

“…Para os testes empíricos, utilizou-se o modelo de Feltham e Ohlson (1995) numa amostra de empresas de capital aberto, no período de 2010.4 a 2014.2. …”
Get full text

LAS INCERTIDUMBRES NORMALES Y LOS INFORMES CONTABLES FINANCIEROS by CARLOS LUIS GARCÍA CASELLA

“…Basándonos en una propuesta de Mattessich, recurrimos a los trabajos de Christensen y Feltham que señalan la importancia de considerar la incertidumbre respecto a los informes contables financieros y gerenciales con el aporte del espacio probabilístico y los trabajos sobre la economía de la información. …”
Get full text

Avaliando Modelos Lineares de Value Relevance: Eles Captam o que Deveriam Captar? by Filipe Coelho de Lima Duarte, Luiz Felipe de Araújo Pontes Girão, Edilson Paulo

“…Seguindo os princípios e fundamentos de Ohlson (1995), Feltham e Ohlson (1995) e Ohlson e Kim (2015), foi possível utilizar um parâmetro de comparação entre os modelos de avaliação da relevância da informação contábil. …”
Get full text

An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart® injection device by Willis H, Webster J, Larkin AM, Parkes L

“…Helen Willis,1 Julie Webster,1 Anne Marie Larkin,2 Laura Parkes,31Broomfield Hospital, Chelmsford, Essex, United Kingdom; 2MySupport Nurse, Quintiles Ireland Ltd, Dublin, Ireland; 3Medical Affairs, Merck Serono Ltd, Feltham, United KingdomBackground: Poor adherence to disease-modifying drugs is associated with an increased risk of relapse in patients with multiple sclerosis. …”
Get full text

A concise history of analytical accounting: examining the use of mathematical notions in our discipline by Richard Mattessich

“…Estos esfuerzos han sido resumidos recientemente en la obra en dos volúmenes de Christensen y Feltham (2003, 2005).…”
Get full text

Patient expectations and experiences of multiple sclerosis interferon ß-1a treatment: a longitudinal, observational study in routine UK clinical practice by Syed M, Rog D, Parkes L, Shepherd GL

“…Mehmood Syed,1 David Rog,2 Laura Parkes,3 Gillian L Shepherd3 1Bupa Home Healthcare, Harlow, Essex, 2Department of Neurology, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, 3Medical Affairs, Merck Serono Ltd, Feltham, Middlesex, UK Background: Premature discontinuation and poor treatment adherence are problems in chronic conditions, such as multiple sclerosis in which patients must take long-term treatment in order to receive maximum benefit from their medication. …”
Get full text

Microbiología del agua termal del balneario Ilaló. Pichincha. Ecuador by Diana Sacoto-Acaro, Félix Daniel Andueza-Leal

“…Se realizó la cuantificación, aislamiento e identificación de las cepas bacterianas de acuerdo con las pruebas sugeridas por Barrow y Feltham (2003), siguiendo los esquemas propuestos por MacFaddin (2004), complementadas con el kit de identificación bacteriana Microgen. …”
Get full text

Crystal structure of a Pd4 carbonyl triphenylphosphane cluster [Pd4(CO)5(PPh3)4]·2C4H8O, comparing solvates by Koen Robeyns, Christopher Willocq, Bernard Tinant, Michel Devillers, Sophie Hermans

“…Acta, 373, 233–242], and in particular to the desolvated structure [Feltham et al. (1985). Inorg. Chem. 24, 1503–1510]. …”
Get full text

Microbiota extremofila y resistomas ambientales de la fuente termal “Termas La Merced” Quito-Ecuador by Gerardo Medina-Ramírez, Carina Naranjo, Sandra Escobar, Judith Araque, Pablo Djabayan, Félix Andueza

“…Se realizó el aislamiento bacteriano, utilizando las placas de PetrifilmTM, para bacterias aerobias mesófilas La identificación de las colonias bacterianas se realizó de acuerdo a las pruebas sugeridas por MacFaddin (2003) y Barrow y Feltham (1993), suplementadas con las pruebas de identificación bacteriano MicrogenTM. …”
Get full text

Phân lập và khảo sát sự đề kháng kháng sinh của các chủng vi khuẩn Escherichia coli trên vịt tại tỉnh Vĩnh Long by Cao Thuấn, Lý Thị Liên Khai

“…Phương pháp phân lập vi khuẩn  Escherichia coli được thực hiện theo quy trình của Barrow and Feltham (2003) và tiêu chuẩn Việt Nam, TCVN 5155-90. …”
Get full text

Recensiones de libros by Gonzalo Fernández, Rafael González Fernández, Susan Bock, Manuel López Campuzano, Antonino González Blanco, Antonio Yelo Templado

“…Reimpresión de la 2: edición de 1982. Feltham (Middlesex) , 1983.   MOMIGLIANO , Arnaldo: Probkmes d 'historiographie ancienne et moderne, traducción francesa de A. …”
Get full text

Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial by John E. McKinnon, Joel Santiaguel, Claudia Murta de Oliveira, Dongzi Yu, Mukhy Khursheed, Flavie Moreau, Lena Klopp‐Schulze, Jamie Shaw, Sanjeev Roy, Amy H. Kao, the ANEMONE Study Team

Get full text

Patient assessment of an electronic device for subcutaneous self-injection of interferon ß-1a for multiple sclerosis: an observational study in the UK and Ireland by D'Arcy C, Thomas D, Stoneman D, Parkes L

“…Caroline D’Arcy1, Del Thomas2, Dee Stoneman3, Laura Parkes31West London Neuroscience Centre, Charing Cross Hospital, London, UK; 2Wye Valley NHS Trust, Hereford, UK; 3Merck Serono Ltd, Feltham, Middlesex, UKBackground: Injectable disease-modifying drugs (DMDs) reduce the number of relapses and delay disability progression in patients with relapsing–remitting multiple sclerosis (RRMS). …”
Get full text

Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multip... by Lin YT, Will T, Wickham C, Boeree P, Jack D, Keiser M

“…Yu-Ting Lin,1 Tamara Will,2 Charlotte Wickham,3 Petra Boeree,2 Dominic Jack,4 Matthew Keiser1,5 1Device and Connected Solution Engineering, Global Healthcare Operations, Ares Trading SA (an affiliate of Merck KGaA), Eysins, Switzerland; 2Human Factors Research & Design, Emergo by UL, Utrecht, the Netherlands; 3Human Factors Research & Design, Emergo by UL, Cambridge, UK; 4Medical Unit Neurology & Immunology, Global Research & Development, Merck Serono Ltd (an affiliate of Merck KGaA), Feltham, UK; 5Device and Connected Solution Engineering, Global Healthcare Operations, EMD Serono, Inc (an affiliate of Merck KGaA), Rockland, MA, USACorrespondence: Yu-Ting Lin, Device and Connected Solution Engineering, Global Healthcare Operations, Ares Trading SA (an affiliate of Merck KGaA), Rte de Crassier 1, Eysins, 1262, Switzerland, Tel +41 796874022, Email yu-ting.lin@merckgroup.comBackground: The RebiSmart® electromechanical autoinjector supports people living with relapsing multiple sclerosis (MS) with their adherence to treatment with subcutaneous interferon beta-1a (sc IFN β-1a; Rebif®), a well-established and effective therapy. …”
Get full text

Identification and treatment of offenders with attention-deficit/hyperactivity disorder in the prison population: a practical approach based upon expert consensus by Susan Young, Gisli Gudjonsson, Prathiba Chitsabesan, Bill Colley, Emad Farrag, Andrew Forrester, Jack Hollingdale, Keira Kim, Alexandra Lewis, Sarah Maginn, Peter Mason, Sarah Ryan, Jade Smith, Emma Woodhouse, Philip Asherson

Get full text

Preferences and Perspectives of Specialist Multiple Sclerosis Nurses and Patients with Multiple Sclerosis Regarding the New RebiSmart® 3.0 Autoinjector versus Other Assistive D... by Colten SS, di Cantogno EV, Jack D

“…(an Affiliate of Merck KGaA), Feltham, UKCorrespondence: Sridevi S Colten, EMD Serono Research and Development Institute, Inc. …”
Get full text

The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis by Rozemarijn M. Mattiesing, Giordano Gentile, Iman Brouwer, Ronald A. van Schijndel, Bernard M.J. Uitdehaag, Jos W.R. Twisk, Ludwig Kappos, Mark S. Freedman, Giancarlo Comi, Dominic Jack, Nicola De Stefano, Frederik Barkhof, Marco Battaglini, Hugo Vrenken

Get full text

The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previou... by Nicola Huxley, Louise Crathorne, Jo Varley-Campbell, Irina Tikhonova, Tristan Snowsill, Simon Briscoe, Jaime Peters, Mary Bond, Mark Napier, Martin Hoyle

“…Targeted agents are available, including the antiepidermal growth factor receptor (EGFR) agents cetuximab (Erbitux®, Merck Serono UK Ltd, Feltham, UK) and panitumumab (Vecitibix®, Amgen UK Ltd, Cambridge, UK). …”
Get full text